Fundz

Cleopatra Rx Development reported raising $250,000 in an initial SEC Form D filing, from an offering of $2 Million

PRIVATEMar 31, 2023$250K of $2M raised

Amount Raised

$250,000

$250,000 sold, per SEC Form D (first sale Mar 22, 2023)

Round Type

Venture

The WoodlandsHealthcare

Who else raised in Healthcare around the same time

Companies in the same sectors as CleopatraRX Development that raised within 45 days of this round, from Fundz verified event records.

  • Enamel Pure raised $380K (Seed) on May 5, 2023.
  • Polaris Genomics raised $1M (Seed) on May 5, 2023.
  • Singletto raised $200K (Pre-Seed) on May 5, 2023.
  • Eledon raised $35M on May 5, 2023.
  • MorphImmune Inc. raised $15M on May 5, 2023.
  • Yuvo, Inc. raised $10M on May 4, 2023.

Who to call at CleopatraRX Development, and when

A new round usually means CleopatraRX Development is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day CleopatraRX Development raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at CleopatraRX Development, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at CleopatraRX Development. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

CleopatraRX Development

Location

8000 RESEARCH FOREST DRIVE

The Woodlands, Texas, United States

About

Cleopatra RX provides women who have cognitive difficulties from menopause with cutting-edge treatments and supplements to eliminate brain fog and give them a clearer mind. The key to cognitive decline curing menopause is to be proactive, not reactive, when it comes to brain health. Estrogen and progesterone are vital hormones that protect against brain aging, neurodegeneration and brain atrophy. At the onset of menopause, these hormones drop sharply causing a range of symptoms including night sweats, hot flashes, mood swings, and brain fog. Developed by Neuroscientist and World-Renowned Expert in Brain Health, Rhonda R. Voskuhl, M.D. Rhonda Voskuhl, M.D. is a research scientist and professor of neurology at UCLA. Director of the Brain Research Institute (BRI). Her discovery of estrogen loss and its effect on cognition, was identified during her extensive research on cognitive function in individuals with multiple sclerosis. Menopause affects every woman differently. The list of symptoms that may occur during perimenopause and menopause is long. One of the more significant effects involves cognitive difficulties, also known as “brain fog”. Brain fog is characterized by a decline in active memory, long-term memory, and the ability to focus. The PearlPAK™* Advantage PearlPAK™ is a treatment designed to actively slow down degenerative effects in the brain caused by perimenopause and menopause. *PearlPAK™️ dose system is not intended to treat neurological diseases including dementia and Alzheimer’s Disease. It is specifically designed to target cognitive difficulties in perimenopause and early menopausal women only. CleopatraRX™ and PearlPAK™ are trademarks of CleopatraRX Development, LLC. CleopatraRX™ is a service mark and is used to represent the services offered by CleopatraRX Development, LLC. PearlPAK™ is a dosage product for use as a drug/routine system and/or treatment.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment CleopatraRX Development raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for CleopatraRX Development's next move

See what Strategic adds

CleopatraRX Development raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.